Please login to read the full article.
Scrip Regulatory Affairs
Indian govt paper to reignite debate on compulsory licensing
01 September 2010
Anju Ghangurde
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Weakened role for Brazilian medicines agency in granting patents is not enough, says industry
- Stakeholders support exemption of in-house IVDs from EU directive, with conditions
- FDA device chief defends US review process at govt hearing
- European generics firms, squeezed between innovators and payers, seek diversity
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Other Informa Comments
